[Progressively acting antithrombins and plasma heparin resistance in ischemic heart disease].
A comparative study of activity of the progressively acting antithrombin and their heparin-cofactor activity was undertaken in 27 patients with angina pectoris and 46 with macrofocal myocardial infarction. It was established that the count of thrombin inactivation during 5 minutes (Abiligaard method) shows no disorders in the majority of patients. Only in 3 patients with the primary antithrombin III and 3 (40% of patients with acute myocardial infarction showed a marked decrease of this parameter. Inactivation count of the endogenous thrombin according to the "self-coagulogram" during one hour enabled one to show decrease of activity of antithrombin in of 80% of patients. The heparin-cofactor activity in the serial heparin-thrombin test is markedly disrupted, which was used to compute the indices of activity of antithrombin and of the antithrombin plasma reserve. This disorder did not depend much on the increase of the antiheparin factor of thrombocytes in plasma.
D000328:Adult; D000368:Aged; D000787:Angina Pectoris / Q000097:blood; D000990:Antithrombin III / Q000502:physiology; D000991:Antithrombins / Q000502:physiology*; D003327:Coronary Disease / Q000097:blood*; D004351:Drug Resistance; D005260:Female; D006493:Heparin; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000097:blood; D013918:Thrombin Time
D000991:Antithrombins; D000990:Antithrombin III; D006493:Heparin
Progressivno deĭ stvuiushchie antitrobiny i geparinorezistentnost'plazmy u bol'nykh ischemicheskoĭ bolezn'iu serdtsa.